These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23683669)
1. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC). Alves G; Pereira DA; Sandim V; Ornellas AA; Escher N; Melle C; von Eggeling F Int Braz J Urol; 2013; 39(2):228-39. PubMed ID: 23683669 [TBL] [Abstract][Full Text] [Related]
2. [Screening urine markers of renal cell carcinoma using SELDI-TOF-MS]. Wu DL; Wang WJ; Guan M; Jin SB; Jin CR; Zhang YF Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1092-5. PubMed ID: 15312509 [TBL] [Abstract][Full Text] [Related]
4. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern. Wu DL; Zhang WH; Wang WJ; Jing SB; Xu YM Technol Cancer Res Treat; 2008 Jun; 7(3):155-60. PubMed ID: 18473487 [TBL] [Abstract][Full Text] [Related]
5. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769 [TBL] [Abstract][Full Text] [Related]
6. Screening for the serum differential proteins of renal cell carcinoma using magnetic beads-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Liu JS; Li HZ; Zhang YS; Wang P; Yan WG; Xie J; Dong DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):287-91. PubMed ID: 21718612 [TBL] [Abstract][Full Text] [Related]
7. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516 [TBL] [Abstract][Full Text] [Related]
8. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528 [TBL] [Abstract][Full Text] [Related]
9. Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma. Nuerrula Y; Rexiati M; Liu Q; Wang YJ Cancer Biomark; 2015; 15(4):485-91. PubMed ID: 26406868 [TBL] [Abstract][Full Text] [Related]
10. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. Geng X; Wang F; Li YG; Zhu GP; Zhang WM J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545 [TBL] [Abstract][Full Text] [Related]
11. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS). O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431 [TBL] [Abstract][Full Text] [Related]
12. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues. Vieira de Ribeiro AJ; Sandim V; Ornellas AA; Reis RS; Domont G; Alves G Int Braz J Urol; 2013; 39(1):83-94. PubMed ID: 23510786 [TBL] [Abstract][Full Text] [Related]
13. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Liu XP; Shen J; Li ZF; Yan L; Gu J Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557 [TBL] [Abstract][Full Text] [Related]
14. Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology. Nakamura K; Yoshikawa K; Yamada Y; Saga S; Aoki S; Taki T; Tobiume M; Shimazui T; Akaza H; Honda N Int J Oncol; 2006 Apr; 28(4):965-70. PubMed ID: 16525647 [TBL] [Abstract][Full Text] [Related]
15. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221 [TBL] [Abstract][Full Text] [Related]
16. Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. Johnston O; Cassidy H; O'Connell S; O'Riordan A; Gallagher W; Maguire PB; Wynne K; Cagney G; Ryan MP; Conlon PJ; McMorrow T Proteomics Clin Appl; 2011 Aug; 5(7-8):422-31. PubMed ID: 21751411 [TBL] [Abstract][Full Text] [Related]
17. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology]. Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445 [TBL] [Abstract][Full Text] [Related]
18. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Novikova SI; He F; Cutrufello NJ; Lidow MS Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361 [TBL] [Abstract][Full Text] [Related]
19. A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes. Del Boccio P; Raimondo F; Pieragostino D; Morosi L; Cozzi G; Sacchetta P; Magni F; Pitto M; Urbani A Electrophoresis; 2012 Feb; 33(4):689-96. PubMed ID: 22451062 [TBL] [Abstract][Full Text] [Related]
20. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]